Philippe Lambin
13Patents
5h-index
37Co-inventors
62Inventor score
Filing activity: Apr 16, 2007 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7805385B2 | Prognosis modeling from literature and other sources | Physics | 114 | Active |
| US9721340B2 | Systems, methods and devices for analyzing quantitative information obtained from radiological images | Physics | 92 | Active |
| US8078554B2 | Knowledge-based interpretable predictive model for survival analysis | Human Necessities | 53 | Active |
| US10339653B2 | Systems, methods and devices for analyzing quantitative information obtained from radiological images | Physics | 21 | Active |
| US8812240B2 | Dose distribution modeling by region from functional imaging | Human Necessities | 7 | Active |
| US8250013B2 | System and method for privacy preserving predictive models for lung cancer survival analysis | Physics | 4 | Active |
| US9811904B2 | Method and system for determining a phenotype of a neoplasm in a human or animal body | Physics | 3 | Active |
| US8032308B2 | Modeling lung cancer survival probability after or side-effects from therapy | Human Necessities | 1 | Active |
| US10311571B2 | Image analysis method supporting illness development prediction for a neoplasm in a human or animal body | Physics | 0 | Active |
| US11972867B2 | Method of training a machine learning data processing model, method of determining a hypoxia status of a neoplasm in a human or animal body, and system therefore | Physics | 0 | Active |
| US8980932B2 | Cancer targeting using carbonic anhydrase isoform IX inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12102842B2 | Treatment and planning for lymphocytes sparing radiotherapy | Human Necessities | 0 | Active |
| US7960114B2 | Gene signature of early hypoxia to predict patient survival | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.